This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,094.83, is for the delivery of OGIVRI 420 MG VIALS, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime contractor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/7/25, 10:12 AM